Fannin Goldenrod Holdings — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
HealthtechHouston, US
Reynolds, III M. Delagado(Director)Steve Oldham(Director)Leo III E Linbeck(Director)Benjamin A Hertzog(Executive Officer, Director)Jason J Heuring(Executive Officer)
Board seatLeo E Linbeck, III· per SEC Form D · $64M raise · filed Feb 2024
Pulmotect develops PUL-042, a clinical-stage inhaled therapeutic that stimulates the innate immune system in the lungs to protect against viral, bacterial, and fungal pathogens.
BiotechHealthtechHouston, US
Colin Broom(Executive Officer, Director)Mark Worscheh(Director)Leo Linbeck III(Director)
BoardKumar Srinivasan(Director)Atul Varadhachary(Director)
Board seatLeo E. LinbeckLeo E. Linbeck IIILeo Linbeck III· per SEC Form D · filed Sep 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.